Associated Papers
Estimated global prevalence of genetic carriers of hereditary pheochromocytoma-paraganglioma syndrome in a large multiethnic genomic database.
Charoenngam N et al.
European Journal of Endocrinology, 2025
40974092 (PubMed )
Supplement: lvaf191_supplementary_data.docx
Novel Calcium-Binding Ablating Mutations Induce Constitutive RET Activity and Drive Tumorigenesis.
Tabata J et al.
Cancer Research, 2022
36166639 (PubMed )
Supplement: can-22-0834_supplementary_table_s1_suppst1.xlsx › Supplementary_Table_S1
An integrative pan cancer analysis of RET aberrations and their potential clinical implications.
Zhou L et al.
Scientific Reports, 2022
35978072 (PubMed )
Supplement: 41598_2022_17791_MOESM3_ESM.xlsx › table
Association between somatic RET mutations and clinical and genetic characteristics in patients with metastatic colorectal cancer.
Yang YZ et al.
Cancer Medicine, 2021
ctDNA detected by ddPCR reveals changes in tumour load in metastatic malignant melanoma treated with bevacizumab.
Forthun RB et al.
Scientific Reports, 2019
31767937 (PubMed )
Supplement: 41598_2019_53917_MOESM2_ESM.xlsx › Supplementary_Table_1
Diagnostic value of partial exome sequencing in developmental disorders.
Gieldon L et al.
Plos One, 2018
Genetic testing in the clinical care of patients with pheochromocytoma and paraganglioma.
Rana HQ et al.
Current Opinion in Endocrinology, Diabetes, and Obesity, 2014
Screening of the RET gene of Vietnamese Hirschsprung patients identifies 2 novel missense mutations.
Ngo DN et al.
Journal of Pediatric Surgery, 2012
Rett syndrome-causing mutations in human MeCP2 result in diverse structural changes that impact folding and DNA interactions.
Ghosh RP et al.
The Journal of Biological Chemistry, 2008
Select a paper to view details